CytoSorbents Europe GmbH of Berlin at MEDICA 2021 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

CytoSorbents Europe GmbH

Müggelseedamm 131, 12587 Berlin
Germany
Telephone +49 30 65499-145
Fax +49 30 65499-146
support@cytosorbents.com

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

This company is co-exhibitor of
Berlin Partner für Wirtschaft und Technologie GmbH

Hall map

MEDICA 2021 hall map (Hall 15): stand H22

Fairground map

MEDICA 2021 fairground map: Hall 15

Our range of products

Product categories

  • 01  Imaging and diagnostics / medical equipment and devices
  • 01.06  Intense medicine / anesthesiology / respiration
  • 01.06.07  Other equipment for intense medicine / anesthesiology / respiration

Other equipment for intense medicine / anesthesiology / respiration

About us

Company portrait

About us
CytoSorbents Europe GmbH, headquartered in Berlin, is a wholly owned subsidiary of CytoSorbents Corporation of Monmouth Junction, New Jersey, USA, where the CytoSorb product is manufactured. CytoSorb is the company’s flagship product, backed by more than 30 patent families.

CytoSorbents Europe was founded in February 2012 by Dr. Christian Steiner and Dr. Phillip Chan, shortly after the CytoSorb product received CE approval. All sales and marketing activities as well as most of the scientific studies are controlled and organized from Berlin.

Since the start in 2012, the entire company CytoSorbents has taken a very successful development. The products are now represented in 65 countries on five continents. More than 1000 clinical departments work with CytoSorb.

In addition, the number of scientific publications and studies continues to grow year after year. In addition to direct sales in Germany, all products are sold abroad through specialist dealers and global partners such as Fresenius Medical Care (for part of Europe) and Biocon Ltd. (India, Sri Lanka). All of these companies have many years of experience in intensive care and have excellent local market knowledge.

CytoSorbents Corp has been listed on the NASDAQ since December 2014.